Yoshikatsu Eto

Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues

Takashi Yokoo, Toya Ohashi, Jin Song Shen et al. · Proceedings of the National Academy of Sciences · 2005 · 223 citations · Full text

Tissue Engineering, Regeneration, Adult Stem Cell +20

A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II

Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai et al. · Molecular Therapy · 2020 · 159 citations · Full text

Immunology, Neurochemical Biomarkers, Pharmacotherapy +17

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial

Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai et al. · Molecular Therapy · 2018 · 150 citations · Full text

Phase 1/2, Translational Medicine, Autoimmune Disease +14

Japan Elaprase® Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)

Torayuki Okuyama, Akemi Tanaka, Yasuyuki Suzuki et al. · Molecular Genetics and Metabolism · 2009 · 144 citations

Attenuated Hunter Syndrome, Pathogenesis, Japan Elaprase® Treatment +4

N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease

Hou Lin, Yuko Sugimoto, Yuki Ohsaki et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2004 · 125 citations

Gaucher Disease, Biochemistry, Glycosylation +8